Elevated due to degrowth in GWP and uptick in motor business; still among lowest in multi-line market.
Bajajfinsv Ltd — Q4 FY25
Bajaj Finserv reported a steady Q4 FY25 with consolidated total income up 14% YoY to INR 36,596 crore and PAT up 14% to INR 2,417 crore.
✓ Verified against BSE filing
2-Minute Summary
Bajaj Finserv reported a steady Q4 FY25 with consolidated total income up 14% YoY to INR 36,596 crore and PAT up 14% to INR 2,417 crore. The general insurance arm BAGIC saw GWP decline 13% due to accounting changes and volatile crop/government health business, but core retail and commercial lines grew 8-12%, outpacing the industry. Life insurance arm BALIC delivered a strong VNB margin expansion to 22.1% (up ~400bps YoY) driven by product mix shift and cost actions, though PAT fell 61% on lower realized gains. Bajaj Finance continued robust performance with AUM growth of 26% and stable asset quality. Management expressed cautious optimism for H2 FY26, focusing on profitable growth and cost efficiencies. Key risks include regulatory changes, competitive pressure in insurance, and potential market volatility impacting investment gains.
बजाज फिनसर्व की चौथी तिमाही (Q4 FY25) की कमाई अच्छी रही। कुल आय 14% बढ़कर 36,596 करोड़ रुपये और शुद्ध लाभ (PAT) 14% बढ़कर 2,417 करोड़ रुपये हुआ। बीमा कंपनी BAGIC का प्रीमियम 13% घटा, क्योंकि हिसाब-किताब के तरीके बदले और सरकारी स्वास्थ्य बीमा में उतार-चढ़ाव रहा। लेकिन इसकी रिटेल और कमर्शियल बीमा 8-12% बढ़ी। दूसरी बीमा कंपनी BALIC का नया कारोबार मुनाफा (VNB) 22.1% हो गया, जो पिछले साल से 4% ज्यादा है। हालांकि इसका मुनाफा 61% गिरा क्योंकि निवेश से कमाई कम हुई। बजाज फाइनेंस का कर्ज 26% बढ़ा और कर्ज वसूली स्थिर रही। कंपनी अगले साल की दूसरी छमाही में मुनाफे पर ध्यान देगी। जोखिमों में नियमों में बदलाव, बीमा में प्रतिस्पर्धा और बाजार में उतार-चढ़ाव शामिल हैं।
Key Numbers
Expanded from 18% last year, driven by product mix shift and cost efficiencies.
Driven by strong loan growth across segments; customer franchise crossed 100 million.
Reflects strategic focus on protection business; premium grew from INR 241 crore in FY24.
What Changed vs Last Quarter
Management expects VNB margin expansion to accelerate, with benefits from cost actions and product mix fully playing out by FY27, but visible from H2 FY26.
Management aims to maintain profitable growth, prioritizing underwriting performance over market share in tender-driven businesses.
Bajaj Finserv Health and Bajaj Markets are expected to increase transaction volumes and achieve greater scale, with health targeting international expansion.
After a muted H1 due to high base and agency channel reset, growth is expected to recover in the second half of FY26.
Continued focus on profitable growth with combined ratio superior to industry average.
Management committed to bringing down loan losses in the coming year.
The 1/n regulation for long-term products distorted GWP and combined ratio comparability, and further regulatory shifts could affect reported metrics.
BALIC's largest bancassurance partner (Axis Bank) contributes 22% of business; the partner's acquisition of a competing insurer could pressure margins or market share.
Lower realized gains in Q4 due to market conditions dragged PAT for both insurance subsidiaries; continued volatility could affect profitability.
Aggressive pricing in crop and government health segments led BAGIC to reduce participation, risking market share loss in these lines.
New surrender value guidelines have impacted product mix and distribution, with agency channel taking longer to adjust.
IRDAI capping senior citizen premium hikes and EOM limits may pressure margins, though Bajaj is well-positioned.
Allianz's intention to exit the JV is at preliminary stage; no details provided, creating strategic uncertainty.
🤫 Topics management stopped discussing
Mentioned in Q3 FY24, Q3 FY25, Q4 FY24
New surrender value guidelines have impacted product mix and distribution, with agency channel taking longer to adjust.
Mentioned in Q2 FY25, Q3 FY25
Allianz's intention to exit the JV is at preliminary stage; no details provided, creating strategic uncertainty.
Mentioned in Q2 FY25, Q4 FY24
Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.
Mentioned in Q3 FY24, Q4 FY24
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Management Guidance
BALIC VNB margin trajectory to steepen
Management expects VNB margin expansion to accelerate, with benefits from cost actions and product mix fully playing out by FY27, but visible from H2 FY26.
Management guidance marginsBALIC top-line growth to pick up from H2 FY26
After a muted H1 due to high base and agency channel reset, growth is expected to recover in the second half of FY26.
Management guidance growthBAGIC to continue calibrated growth with underwriting focus
Management aims to maintain profitable growth, prioritizing underwriting performance over market share in tender-driven businesses.
Management guidance growthPlatform businesses to scale transactions
Bajaj Finserv Health and Bajaj Markets are expected to increase transaction volumes and achieve greater scale, with health targeting international expansion.
Management guidance expansionKey Risks
Regulatory changes impacting insurance accounting
The 1/n regulation for long-term products distorted GWP and combined ratio comparability, and further regulatory shifts could affect reported metrics.
medium · management_commentaryConcentration risk in bancassurance
BALIC's largest bancassurance partner (Axis Bank) contributes 22% of business; the partner's acquisition of a competing insurer could pressure margins or market share.
medium · analyst_questionMarket volatility impacting investment gains
Lower realized gains in Q4 due to market conditions dragged PAT for both insurance subsidiaries; continued volatility could affect profitability.
medium · data_observationCompetitive pressure in tender-driven insurance lines
Aggressive pricing in crop and government health segments led BAGIC to reduce participation, risking market share loss in these lines.
low · management_commentaryNotable Quotes
We are using this opportunity on Team AI and BFL in looking at our OpEx cost in Band-Aid and the margin profiles, restructuring the business on different charges.
We have also taken significant calls on cost structures, looking at more productive investments, removing wastage, inefficiency, and some places significant cost cuts. This is helping us leverage to an extent you saw that operating leverage show up in Q4.
If the CBR rule changes, if the fact gets more difficult, we have enough to be able to retain also, and we have enough underwriting competence, which you demonstrated for several years, to write good risk.
Frequently Asked Questions
What was Bajajfinsv's revenue in Q4 FY25?
Bajajfinsv reported revenue of ₹36,595 Cr in Q4 FY25, representing a +14% change compared to the same quarter last year.
What guidance did Bajajfinsv management give for FY26?
BALIC VNB margin trajectory to steepen: Management expects VNB margin expansion to accelerate, with benefits from cost actions and product mix fully playing out by FY27, but visible from H2 FY26. BALIC top-line growth to pick up from H2 FY26: After a muted H1 due to high base and agency channel reset, growth is expected to recover in the second half of FY26. BAGIC to continue calibrated growth with underwriting focus: Management aims to maintain profitable growth, prioritizing underwriting performance over market share in tender-driven businesses. Platform businesses to scale transactions: Bajaj Finserv Health and Bajaj Markets are expected to increase transaction volumes and achieve greater scale, with health targeting international expansion.
What are the key risks for Bajajfinsv in FY26?
Key risks include Regulatory changes impacting insurance accounting — The 1/n regulation for long-term products distorted GWP and combined ratio comparability, and further regulatory shifts could affect reported metrics.; Concentration risk in bancassurance — BALIC's largest bancassurance partner (Axis Bank) contributes 22% of business; the partner's acquisition of a competing insurer could pressure margins or market share.; Market volatility impacting investment gains — Lower realized gains in Q4 due to market conditions dragged PAT for both insurance subsidiaries; continued volatility could affect profitability.; Competitive pressure in tender-driven insurance lines — Aggressive pricing in crop and government health segments led BAGIC to reduce participation, risking market share loss in these lines..
Did Bajajfinsv meet its previous quarter's guidance?
Of 2 tracked promises, management 0 met, 0 close, 2 missed.
Where can I read the full Bajajfinsv Q4 FY25 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.